IP Verse

Interleukin-31 Monoclonal Antibody

Patent No. EP3653645 (titled "Interleukin-31 Monoclonal Antibody") was filed by Zoetis Services on Jul 5, 2012. The application was issued on Aug 21, 2024.

Patent Summary

Anti-IL-31 antibodies for treating pruritic conditions in dogs and cats, comprising a variable light chain and a variable heavy chain, and variants thereof with conservative amino acid substitutions. The antibodies specifically bind to canine IL-31, inhibit its activity, and prevent its binding to the IL-31 receptor complex. The antibodies are useful for treating conditions such as atopic dermatitis, eczema, and pruritus in dogs and cats.

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MARGARET DIXONMay 21, 2025MEWBURN ELLIS
BOEHRINGER INGELHEIMMay 20, 2025D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3653645

ZOETIS SERVICES
Application Number
EP19196963A
Filing Date
Jul 5, 2012
Status
Granted And Under Opposition
Jul 19, 2024
Publication Date
Aug 21, 2024
External Links
Slate, Register , Google Patents